Bioethics, Ltd.
Other OTCTotal Valuation
Bioethics, Ltd. carries a market capitalization of 18,360.00, placing it among publicly traded companies globally.
| Market Cap | 18,360.00 |
| Enterprise Value | N/A |
Share Statistics
Bioethics, Ltd. currently has 3.34M shares outstanding.
| Shares Outstanding | 3.34M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Valuation Ratios
| PE Ratio | N/A |
| PS Ratio | N/A |
| PB Ratio | -0.90 |
| P/TBV Ratio | -1.40 |
| P/FCF Ratio | -8.68 |
| P/OCF Ratio | -8.68 |
Financial Position
Bioethics, Ltd. maintains a current ratio of 0.02, meaning it holds 0.0x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 0.02 |
| Quick Ratio | 0.02 |
| Debt / Equity | N/A |
| Debt / EBITDA | N/A |
| Interest Coverage | -2.27 |
Financial Efficiency
| Return on Equity (ROE) | N/A |
| Return on Assets (ROA) | -2,390.96 |
| Return on Invested Capital (ROIC) | N/A |
| Return on Capital Employed (ROCE) | N/A |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | N/A |
Stock Price Statistics
Bioethics, Ltd.'s stock has declined approximately -99.592% over the past 52 weeks. The 50-day moving average sits at 0.01, while the 200-day moving average is 0.16.
| Beta (5Y) | N/A |
| 52-Week Price Change | -99.592% |
| 50-Day Moving Average | 0.01 |
| 200-Day Moving Average | 0.16 |
| Average Volume (20 Days) | N/A |
Income Statement
EBITDA reached -122,818.00, while operating income came in at -122,818.00.
| Revenue | N/A |
| Gross Profit | N/A |
| Operating Income | -122,818.00 |
| Pretax Income | -176,955.00 |
| Net Income | -176,955.00 |
| EBITDA | -122,818.00 |
| EBIT | -122,818.00 |
| Earnings Per Share (EPS) | -0.16 |
Balance Sheet
Total book value stands at -1.45M, with working capital of -931,220.00 providing operational flexibility.
| Cash & Cash Equivalents | 14,664.00 |
| Total Debt | N/A |
| Net Debt | 571,025.00 |
| Equity (Book Value) | -1.45M |
| Book Value Per Share | -1.28 |
| Working Capital | -931,220.00 |
Cash Flow
Bioethics, Ltd. produced -150,429.00 in operating cash flow over the past twelve months.
| Operating Cash Flow | -150,429.00 |
| Capital Expenditures | N/A |
| Free Cash Flow | -150,429.00 |
| FCF Per Share | -0.13 |
Dividends & Yields
| Dividend Per Share | N/A |
| Dividend Yield | N/A |
| Payout Ratio | N/A |
| Shareholder Yield | -12.64 |
| FCF Yield | -11.52 |
Stock Splits
Bioethics, Ltd.'s most recent stock split took place on November 2, 2020 with a 10:1 split ratio.
| Last Split Date | 11/2/2020 |
| Split Ratio | 10:1 |
Scores
Bioethics, Ltd. posts an Altman Z-Score of -241.91, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | -241.91 |